there is insufﬁcient evidence to determine the balance of beneﬁts and

harms of screening for PAD with the ABI to prevent
future cardiovascular disease outcomes.” The conﬂicting
recommendations and ongoing controversy demonstrate
that although asymptomatic PAD is a sentinel indicator
of cardiovascular morbidity and mortality, speciﬁc treatment pathways for this large PAD subpopulation remain
poorly deﬁned.
PAD primarily results from atherosclerotic occlusion
of the arteries